{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:39:13Z","timestamp":1791563953413,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijcard.2023.131261","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T02:39:49Z","timestamp":1691721589000},"page":"131261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes"],"prefix":"10.1016","volume":"389","author":[{"given":"Allan","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian A.","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patric","family":"Winzap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slayman","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Klingenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.131261_bb0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2023.131261_bb0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","article-title":"Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women","volume":"40","author":"Wang","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131261_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI94601","article-title":"L-carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans","volume":"129","author":"Koeth","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2023.131261_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.ijcard.2023.131261_bb0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131261_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet Hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.ijcard.2023.131261_bb0035","doi-asserted-by":"crossref","first-page":"ehw582","DOI":"10.1093\/eurheartj\/ehw582","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","author":"Li","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131261_bb0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","article-title":"\u03b3-Butyrobetaine is a Proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO","volume":"20","author":"Koeth","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijcard.2023.131261_bb0045","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jth.14234","article-title":"Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk","volume":"16","author":"Zhu","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2023.131261_bb0050","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.118.313142","article-title":"Microbial transplantation with human gut commensals containing CutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential","volume":"123","author":"Skye","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2023.131261_bb0055","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.ijcard.2023.131261_bb0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2023.131261_bb0065","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/db19-0423","article-title":"Disturbed fatty acid oxidation, endoplasmic reticulum stress, and apoptosis in left ventricle of patients with type 2 diabetes","volume":"68","author":"Ljubkovic","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2023.131261_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003620","article-title":"Serum Acylcarnitines and risk of cardiovascular death and acute myocardial infarction in patients with stable angina pectoris","volume":"6","author":"Strand","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2023.131261_bb0075","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.phrs.2015.11.014","article-title":"Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance","volume":"113","author":"Liepinsh","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2023.131261_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2023.131261_bb0085","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","article-title":"New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism","volume":"62","author":"Eid","year":"2019","journal-title":"Diabetologia."},{"key":"10.1016\/j.ijcard.2023.131261_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.thromres.2011.12.026","article-title":"Thrombosis and acute coronary syndrome","volume":"129","author":"Abbate","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2023.131261_bb0095","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/eurheartj\/ehac143","article-title":"Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131261_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcad027","article-title":"Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort","author":"Bruno","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ijcard.2023.131261_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.ijcard.2023.131261_bb0110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/jch.13622","article-title":"Hypertension and patients with acute coronary syndrome: putting blood pressure levels into perspective","volume":"21","author":"Konstantinou","year":"2019","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.ijcard.2023.131261_bb0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(22)01483-0","article-title":"Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation","volume":"400","author":"Wenzl","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2023.131261_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(22)02457-6","article-title":"Application of a sex-specific GRACE score in practice \u2013 Authors\u2019 reply","volume":"401","author":"Wenzl","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.131261_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13424","article-title":"Repurposing colchicine to combat residual cardiovascular risk: the LoDoCo2 trial","volume":"50","author":"Kraler","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2023.131261_bb0130","article-title":"Initial systolic blood pressure associates with systemic inflammation, myocardial injury and outcomes in patients with acute coronary syndromes","author":"Winzap","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ijcard.2023.131261_bb0135","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/heartjnl-2011-300231","article-title":"Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial","volume":"97","author":"Kadakia","year":"2011","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2023.131261_bb0140","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131261_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016874","article-title":"Melbourne interventional group, the prognostic significance of smoking cessation after acute coronary syndromes: an observational, multicentre study from the Melbourne interventional group registry","volume":"7","author":"Yudi","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2023.131261_bb0150","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jcin.2021.06.028","article-title":"Ticagrelor or Prasugrel in patients with acute coronary syndrome in relation to estimated glomerular filtration rate","volume":"14","author":"W\u00f6hrle","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.ijcard.2023.131261_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001007","article-title":"Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study","volume":"6","author":"Syyli","year":"2019","journal-title":"Open Heart."},{"key":"10.1016\/j.ijcard.2023.131261_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2023.05.014","article-title":"Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: a case-cohort analysis","volume":"376","author":"Kraler","year":"2023","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.ijcard.2023.131261_bb0165","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/dc23-0012","article-title":"Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study","volume":"46","author":"Wenzl","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2023.131261_bb0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/jc.2017-02139","article-title":"Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris","volume":"103","author":"Strand","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2023.131261_bb0175","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2014old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.ijcard.2023.131261_bb0180","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/db09-0011","article-title":"Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet\u2013induced obese mice lacking malonyl CoA decarboxylase","volume":"58","author":"Ussher","year":"2009","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2023.131261_bb0185","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma Acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity."},{"key":"10.1016\/j.ijcard.2023.131261_bb0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2337\/db17-1150","article-title":"Elevated medium-chain Acylcarnitines are associated with gestational diabetes mellitus and early progression to type 2 diabetes and induce pancreatic \u03b2-cell dysfunction","volume":"67","author":"Batchuluun","year":"2018","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2023.131261_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/CCM.0000000000003517","article-title":"Increased plasma Acetylcarnitine in Sepsis is associated with multiple organ dysfunction and mortality","volume":"47","author":"Chung","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2023.131261_bb0200","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma Acylcarnitine profiles suggest incomplete long-chain fatty acid \u03b2-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.ijcard.2023.131261_bb0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1096\/fj.14-255901","article-title":"Acylcarnitines: potential implications for skeletal muscle insulin resistance","volume":"29","author":"Aguer","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2023.131261_bb0210","doi-asserted-by":"crossref","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","article-title":"Acylcarnitines activate proinflammatory signaling pathways","volume":"306","author":"Rutkowsky","year":"2014","journal-title":"American Journal of Physiology-Endocrinology and Metabolism."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323011397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323011397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:03:37Z","timestamp":1759093417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323011397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"alternative-id":["S0167527323011397"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131261","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131261"}}